bimekizumab
bimekizumab Basic information
- Product Name:
- bimekizumab
- Synonyms:
-
- bimekizumab
- Research Grade Bimekizumab(DHH28803)
- Anti-IL-17-mAb-UCB
- Anti-IL-17-monoclonal-antibody-UCB
- Anti-interleukin-17-monoclonal-antibody-UCB
- Research Grade Bimekizumab
- Bimekizumab (anti-IL17A&IL-17F)
- CAS:
- 1418205-77-2
- MW:
- 0
- Mol File:
- Mol File
More
Less
bimekizumab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
More
Less
bimekizumab Usage And Synthesis
Uses
Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation[1].
IC 50
IL-17A; IL-17F
References
[1] Shah M, et al. Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells. RMD Open. 2020 Jul;6(2):e001306. DOI:10.1136/rmdopen-2020-001306
bimekizumabSupplier
Wuhan Sunrise Technology Development Co., Ltd.
- Tel
- 27-027-83314682 13554138826
- whsrtech@vip.163.com
Shanghai EFE Biological Technology Co., Ltd.
- Tel
- 021-65675885 18964387627
- info@efebio.com
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
Guangzhou Hongyuan Chemical Co.,Ltd
- Tel
- 15817493340
- 981810490@qq.com